ARTICLE | Clinical News
INS001: Phase Ib data
June 17, 2013 7:00 AM UTC
Top-line data from an open-label, dose-escalation Phase Ib trial in patients with drug-resistant epilepsy showed that INS001 was well tolerated and increased cardiac parasympathetic tone and electrica...